Award winner - 2024 Luis Villalobos Award recognizing the Innovative Company of the Year for 2024 for Life Sciences! Read more on our News page.
Innovation in Soft Tissue Surgery and Hernia Repair
Next Generation Surgical Devices for Optimal Tissue Tension, Reinforcement, and Defect Closure
Deep Blue is transforming soft tissue surgery by developing and launching next generation surgical devices for optimal tissue tension, reinforcement, and defect closure.
Our portfolio features the T-Line® Hernia Mesh product line and introduces the T-Line® TCS* (Tissue Control Suture) line. Failure in soft tissue surgery due to suture pull-through of tissue or mesh is common, and is often related to a lack of fast, reliable reinforcement that reduces tissue stress. Soft tissue repair dehiscence and hernia repair failure can result—optimal tissue tension and reinforcement is difficult but critical.
T-Line® Scaffold* for Breast Surgery & the Anchor Clip* round-out our four-category product portfolio in development.
For hernia surgery: Now being used in surgical suites across the US, our novel T-Line Hernia Mesh has the potential to significantly impact the $1.1B global hernia device market and improve the high rate of hernia recurrence. Our goal is to provide a superior surgical experience and better patient outcomes. Also under development is an Anchor Clip* for potentially faster, easier implantation; a biosynthetic version* of the T-Line Hernia Mesh; and a coated composite version* of the T-Line Hernia Mesh.
For other soft tissue surgery procedures: Our T-Line® TCS* (Tissue Control Suture) is currently in development and is intended to make procedures quicker, safer, and more durable while delivering a better patient experience with the potential for less pain due to less “cheese wire” effect.
* These products are under development and are for Investigational Use Only in all markets